C4A and systemic lupus erythematosus: The conventional biomarkers for SLE, including complement components 3 and 4 (C3, C4) and anti-double-stranded DNA antibodies (ANA), have low sensitivity (49-79%) and specificity (51-74%) for concurrent renal flare [3].